Position in ARWR
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$25,330,129
+$17,210,542 QoQ
Shares Held
310,761
+140.0% QoQ
Ownership
0.220%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#54
of 497 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 11%
Shared 0%
None 89%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LPL Financial LLC holds $551,304,275 across 203 Biotechnology names. ARWR ranks #3 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
289,111 | $143,610,107 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
65,755 | $41,000,872 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
This page
|
310,761 | $25,330,129 | |
| 4 | ARGX |
Argenx SE
|
19,499 | $18,090,587 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
57,890 | $17,426,626 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
203,557 | $15,932,406 | |
| 7 | RPRX |
Royalty Pharma plc
|
249,117 | $13,967,990 | |
| 8 | INSM |
INSMED Inc
|
128,553 | $13,706,320 |
All Filings in ARWR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,330,129 | 310,761 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $8,119,587 | 129,499 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $6,657,390 | 100,277 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,730,156 | 50,164 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $682,054 | 43,168 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $349,139 | 27,405 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $285,609 | 15,192 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $292,738 | 15,113 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $405,158 | 15,589 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $475,675 | 16,632 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $585,041 | 19,119 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $507,278 | 18,879 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $593,311 | 16,638 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $372,059 | 14,648 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $585,524 | 14,436 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $412,034 | 12,467 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $449,103 | 12,755 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $725,078 | 15,766 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,209,046 | 18,236 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,193,411 | 19,116 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $789,854 | 9,537 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $568,807 | 8,578 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $682,359 | 8,893 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $493,080 | 11,451 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $559,871 | 12,963 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $340,061 | 11,820 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||